Published in Blood Weekly, September 30th, 2004
According to a study from the United States, "There are many considerations for stopping and changing antiretroviral (ARV) therapy in the ARV-experienced individual.
"Given the potential for possible long-term toxicities and the shift to initiating ARV therapy later, it may be reasonable to stop ARV therapy among asymptomatic patients with high CD4 cell counts and low viral loads and carefully monitor them. Ongoing studies are currently evaluating this strategy."
"Treatment regimen failure may be due to problems with tolerability, adherence,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.